GB Patent

GB8608080D0 — Solid dispersion composition

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1986-05-08 · 40y expired

What this patent protects

A solid dispersion composition comprising 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinyl [23,25-dimethoxy-13, 19,21, 27-tetramethyl-11,28-dioxa-4-azatricyclo [22.3.1.0<4,9>] octacos-18-ene-2,3,10,16-tetraone and a water-soluble polymer, and pro…

USPTO Abstract

A solid dispersion composition comprising 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinyl [23,25-dimethoxy-13, 19,21, 27-tetramethyl-11,28-dioxa-4-azatricyclo [22.3.1.0<4,9>] octacos-18-ene-2,3,10,16-tetraone and a water-soluble polymer, and processes for preparing such solid dispersion composition.

Drugs covered by this patent

Patent Metadata

Patent number
GB8608080D0
Jurisdiction
GB
Classification
—
Expires
1986-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.